Post Archive by Month

Common symptoms developing three or more months after COVID-19 infection differ between adults and children/adolescents

Elevated SBP showed dose-response relationship with severe COVID-19 for those taking antihypertensive meds

Patients with acute ischemic stroke and COVID-19 also had worse clinical outcomes, including increased mortality

Rate of myocarditis higher after receipt of mRNA-1273, particularly for younger men (younger than 40 years)

Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo

Survival to hospital discharge higher with use of double sequential external defibrillation compared with standard defibrillation

From 1999 to 2020, mortality rates increased from 0.3 to 0.6 per 100,000 persons among young U.S. residents

Significant reductions seen in blood pressure and LDL-C at six and 12 months for patients enrolled in remote program

Outcomes better for surgical revascularization versus endovascular therapy for those with single segment of great saphenous vein that could be used for surgery

In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo